Themis Medicare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083B01024
  • NSEID: THEMISMED
  • BSEID: 530199
INR
70.82
-4.72 (-6.25%)
BSENSE

Mar 23

BSE+NSE Vol: 1.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
Anuh Pharma
Sigachi Indust.
Shree Ganesh Rem
Kopran
Themis Medicare
Kilitch Drugs
Bharat Parenter.
Anlon Healthcare
Remus Pharma.
Accent Microcell

Why is Themis Medicare Ltd ?

1
Poor long term growth as Operating profit has grown by an annual rate -185.54% of over the last 5 years
2
Flat results in Dec 25
  • PAT(Latest six months) At Rs 7.32 cr has Grown at -50.60%
  • NET SALES(Latest six months) At Rs 168.12 cr has Grown at -20.25%
  • ROCE(HY) Lowest at -3.47%
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -55.46%, its profits have fallen by -135.9%
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Below par performance in long term as well as near term
  • Along with generating -55.46% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Themis Medicare for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Themis Medicare
-55.46%
-0.95
58.22%
Sensex
-5.47%
-0.43
12.65%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.43%
EBIT Growth (5y)
-185.54%
EBIT to Interest (avg)
4.63
Debt to EBITDA (avg)
0.30
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.86
Tax Ratio
4.66%
Dividend Payout Ratio
10.57%
Pledged Shares
2.43%
Institutional Holding
0.07%
ROCE (avg)
13.22%
ROE (avg)
14.31%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
32
Price to Book Value
1.72
EV to EBIT
-37.85
EV to EBITDA
-80.07
EV to Capital Employed
1.59
EV to Sales
2.18
PEG Ratio
NA
Dividend Yield
0.71%
ROCE (Latest)
-4.46%
ROE (Latest)
-7.10%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 3.56 times

PBDIT(Q)

Highest at Rs 9.79 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 10.86%

PBT LESS OI(Q)

Highest at Rs 9.98 cr.

PAT(Q)

Highest at Rs 10.94 cr.

EPS(Q)

Highest at Rs 1.10

-15What is not working for the Company
PAT(Latest six months)

At Rs 7.32 cr has Grown at -50.60%

NET SALES(Latest six months)

At Rs 168.12 cr has Grown at -20.25%

ROCE(HY)

Lowest at -3.47%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 12.75 cr

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.97 times

Loading Valuation Snapshot...

Here's what is working for Themis Medicare

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 9.98 cr has Grown at 217.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -8.49 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 10.94 cr has Grown at 262.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs -6.75 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 3.56 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit (PBDIT) - Quarterly
Highest at Rs 9.79 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 10.86%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 9.98 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 10.94 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 1.10
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Themis Medicare

Net Sales - Latest six months
At Rs 168.12 cr has Grown at -20.25%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 12.75 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Lowest at 1.97 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio